- AdventHealth Research Institute
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt sleep and concentration, negatively impacting daily quality of life and mental health. There is currently no cure.
That is why the AdventHealth Research Institute is excited to be participating in a new multi-site clinical trial funded by the U.S. Department of Defense. Under the leadership of Principal Investigator Michael Seidman, MD, this study will evaluate the efficacy of etanercept, a TNF-alpha blocker, as a potential treatment for blast-induced tinnitus. Click the button below to learn more.
Recent News
The adventHealth is excited to announce the launch of the SOMMA study. This study aims to better understand how our muscles and mobility function change as we age.
We are proud to announce the launch of the new RISE study.
Dr. Iswanto Sucandy was recently featured on AdventHealth West Florida Division’s “Team Talk” to discuss his groundbreaking textbook.
AdventHealth Research Institute’s new review, authored by Drs. Katie Whytock and Bret Goodpaster and published in Circulation Research, highlights how skeletal muscle regulates insulin and glucose...
On July 10, 2025, AdventHealth Director of Neuroscience Clinical Research Anita Fletcher, MD, worked with NKGen Biotech to administer the first dose of troculeucel (SNK01), an investigative natural...
In our latest Clinician’s View, Dr. Seminerio shares her personal passion for improving care for patients with inflammatory bowel disease (IBD) and talks about how AdventHealth’s recently established...
Join the AdventHealth Translational institute as we give a behind the scenes tour of our Translational Research Institute to our friends at Breakthrough T1D.
Under the leadership of Principal Investigator Valeria Baldivieso, MD, and Sub-Investigator Chandan Reddy, MD, MS, FAANS, the AdventHealth Research Institute is recruiting patients for the Exablate...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative...
For people with Type 1 diabetes (T1D), low blood sugar episodes—also known as hypoglycemia—can strike fast and hard. The body’s natural defense is to release hormones like glucagon to raise blood...
A new study reveals that people newly diagnosed with Type 2 diabetes face a significantly higher risk of developing aggressive cancers—including those of the liver, pancreas, and colon.
Dr. Richard Pratley, Samuel E. Crockett Chair in Diabetes Research and Medical Director of AdventHealth Diabetes Institute, recently shared insights with Healio Endocrinology about the importance of...